Johnson & Johnson (JNJ) Accounts Payables (2009 - 2026)

Johnson & Johnson has disclosed Accounts Payables across 18 years of filings, most recently posting $10.5 billion for Q1 2026.

• Accounts Payables for Q1 2026 came in at $10.5 billion, up 9.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 billion (up 9.59% YoY), and the FY2025 annual result was $12.0 billion, up 16.29% from the prior year.
• Accounts Payables came in at $10.5 billion for Q1 2026 at Johnson & Johnson, down from $12.0 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $12.0 billion in Q4 2025 to a low of $8.2 billion in Q1 2024.
• The 5-year median for Accounts Payables is $9.7 billion (2022), against an average of $9.8 billion.
• Across the five-year window, Accounts Payables fell 17.71% in 2023 and grew 16.77% in 2025, its largest moves.
• Johnson & Johnson's Accounts Payables stood at $10.2 billion in 2022, then retreated by 5.13% to $9.6 billion in 2023, then increased by 7.05% to $10.3 billion in 2024, then gained by 16.29% to $12.0 billion in 2025, then decreased by 12.77% to $10.5 billion in 2026.
• The last three Accounts Payables figures came in at $10.5 billion (Q1 2026), $12.0 billion (Q4 2025), and $9.6 billion (Q3 2025), per Business Quant data.